Phibro Animal Health Corporation (PAHC) Sets 52-Week High; Strong Momentum for Holders

April 23, 2018 - By Nellie Frank

Investors sentiment decreased to 1.41 in Q4 2017. Its down 0.07, from 1.48 in 2017Q3. It dropped, as 17 investors sold Phibro Animal Health Corporation shares while 42 reduced holdings. 25 funds opened positions while 58 raised stakes. 19.14 million shares or 1.25% less from 19.38 million shares in 2017Q3 were reported.
Meeder Asset Mgmt reported 1,421 shares or 0% of all its holdings. Guggenheim Capital Lc reported 32,656 shares or 0% of all its holdings. California Public Employees Retirement System accumulated 36,390 shares. Utd Services Automobile Association invested in 0% or 18,889 shares. Old Bancorporation In stated it has 7,772 shares. Barclays Plc, a United Kingdom-based fund reported 7,235 shares. Texas-based Texas Permanent School Fund has invested 0.01% in Phibro Animal Health Corporation (NASDAQ:PAHC). Cambridge Rech Advisors accumulated 17,345 shares. Aperio Grp Incorporated Ltd Limited Liability Company reported 9,953 shares stake. State Street Corp holds 542,790 shares. Cornerstone Cap Llc invested in 0.03% or 128,021 shares. Arizona State Retirement Systems has invested 0.01% in Phibro Animal Health Corporation (NASDAQ:PAHC). Bessemer Gp accumulated 0% or 27,600 shares. Fdx reported 0.01% in Phibro Animal Health Corporation (NASDAQ:PAHC). American Century Inc, a Missouri-based fund reported 53,527 shares.

Since February 9, 2018, it had 0 buys, and 13 sales for $12.62 million activity. $564,664 worth of Phibro Animal Health Corporation (NASDAQ:PAHC) was sold by BFI Co. – LLC. $564,664 worth of Phibro Animal Health Corporation (NASDAQ:PAHC) was sold by BENDHEIM JACK. 23,163 shares were sold by Bendheim Daniel M, worth $926,717 on Thursday, March 8. 10,000 Phibro Animal Health Corporation (NASDAQ:PAHC) shares with value of $356,200 were sold by Warras Dean J.

The stock of Phibro Animal Health Corporation (NASDAQ:PAHC) hit a new 52-week high and has $46.59 target or 6.00 % above today’s $43.95 share price. The 9 months bullish chart indicates low risk for the $1.77B company. The 1-year high was reported on Apr, 23 by If the $46.59 price target is reached, the company will be worth $105.96M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.11% or $0.05 during the last trading session, reaching $43.95. About 18,747 shares traded. Phibro Animal Health Corporation (NASDAQ:PAHC) has risen 41.44% since April 23, 2017 and is uptrending. It has outperformed by 29.89% the S&P500.

Analysts await Phibro Animal Health Corporation (NASDAQ:PAHC) to report earnings on May, 7 after the close. They expect $0.44 EPS, up 18.92 % or $0.07 from last year’s $0.37 per share. PAHC’s profit will be $17.68 million for 24.97 P/E if the $0.44 EPS becomes a reality. After $0.44 actual EPS reported by Phibro Animal Health Corporation for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

Phibro Animal Health Corporation (NASDAQ:PAHC) Ratings Coverage

Among 3 analysts covering Phibro Animal Health (NASDAQ:PAHC), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Phibro Animal Health has $45.0 highest and $36 lowest target. $40’s average target is -8.99% below currents $43.95 stock price. Phibro Animal Health had 3 analyst reports since February 6, 2018 according to SRatingsIntel. On Tuesday, February 6 the stock rating was maintained by Credit Suisse with “Neutral”. The rating was maintained by Piper Jaffray on Wednesday, February 7 with “Buy”. The rating was maintained by Morgan Stanley on Wednesday, February 7 with “Underweight”.

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition firm primarily in the United States. The company has market cap of $1.77 billion. It operates through three divisions: Animal Health, Mineral Nutrition, and Performance Products. It has a 28.58 P/E ratio. The firm develops, makes, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Phibro Animal Health Corporation (NASDAQ:PAHC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.